IMEMR
EMRO
Volume 6, Issue 3 (2025)
J Clinic Care Skill 2025, 6(3): 129-135 |
Back to browse issues page
Article Type:
Subject:
Ethics code: IR.IAU.AHVAZ.REC.1403.404
History
Received: 2025/05/7 | Accepted: 2025/06/20 | Published: 2025/07/1
Received: 2025/05/7 | Accepted: 2025/06/20 | Published: 2025/07/1
How to cite this article
Choheili H, Marashian F, Safarzadeh S, Asgari P. Effect of Mindfulness-Based Cognitive Therapy and Schema Therapy on Emotion-Focused Coping Strategies and Craving in Individuals with Stimulant Substance Use Disorder. J Clinic Care Skill 2025; 6 (3) :129-135
URL: http://jccs.yums.ac.ir/article-1-436-en.html
URL: http://jccs.yums.ac.ir/article-1-436-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Department of Psychology, Ahvaz Campus (Ahv.C.), Islamic Azad University, Ahvaz, Iran
Abstract (248 Views)
Aims: The high relapse rate among individuals with stimulant use disorder necessitates effective psychological interventions to manage core challenges, such as craving and maladaptive coping strategies. This study aimed to compare the effectiveness of mindfulness-based cognitive therapy and schema therapy on emotion-focused coping strategies and craving in this population.
Materials & Methods: This clinical trial utilized an extensive pre-test, post-test, and follow-up design. The statistical population included all individuals with stimulant use disorder at residential centers in Ahvaz in 2024. A convenience sample of 45 individuals was selected and randomly assigned to two experimental groups (n=15 for mindfulness-based cognitive therapy and n=15 for schema therapy) and a control group (n=15) that received no treatment. Data were collected using the Lazarus Coping Strategies Questionnaire and the Instantaneous Substance Craving Questionnaire. Both experimental groups participated in eight 90-minute sessions. Data were analyzed using repeated measures analysis of variance in SPSS software.
Findings: Both mindfulness-based cognitive therapy and schema therapy were effective in significantly reducing emotion-focused coping strategies and craving in the experimental groups, with these effects sustained at follow-up (p<0.001). While both approaches were equally effective in reducing emotion-focused coping strategies, schema therapy demonstrated a relative superiority in reducing craving compared to mindfulness-based cognitive therapy.
Conclusion: Both mindfulness-based cognitive therapy and schema therapy are effective interventions for reducing emotion-focused coping strategies and craving in individuals with stimulant use disorder..
Materials & Methods: This clinical trial utilized an extensive pre-test, post-test, and follow-up design. The statistical population included all individuals with stimulant use disorder at residential centers in Ahvaz in 2024. A convenience sample of 45 individuals was selected and randomly assigned to two experimental groups (n=15 for mindfulness-based cognitive therapy and n=15 for schema therapy) and a control group (n=15) that received no treatment. Data were collected using the Lazarus Coping Strategies Questionnaire and the Instantaneous Substance Craving Questionnaire. Both experimental groups participated in eight 90-minute sessions. Data were analyzed using repeated measures analysis of variance in SPSS software.
Findings: Both mindfulness-based cognitive therapy and schema therapy were effective in significantly reducing emotion-focused coping strategies and craving in the experimental groups, with these effects sustained at follow-up (p<0.001). While both approaches were equally effective in reducing emotion-focused coping strategies, schema therapy demonstrated a relative superiority in reducing craving compared to mindfulness-based cognitive therapy.
Conclusion: Both mindfulness-based cognitive therapy and schema therapy are effective interventions for reducing emotion-focused coping strategies and craving in individuals with stimulant use disorder..
Keywords:
References
1. Hankins D. Stimulant use disorders. In: Avery J, Makovkina E, editors. Substance use disorders and behavioral addictions: A comprehensive guide. Cham: Springer; 2025. p. 1-20. [Link] [DOI:10.1007/978-3-031-57159-6_63-1]
2. Ramey T, Regier PS. Cognitive impairment in substance use disorders. CNS Spectr. 2019;24(1):102-13. [Link] [DOI:10.1017/S1092852918001426]
3. London ED, Groman SM, Leyton M, De Wit H. The mesocorticolimbic system in stimulant use disorder. Mol Psychiatry. 2025;1. [Link] [DOI:10.1038/s41380-025-03148-0]
4. Iqbal MN, Levin CJ, Levin FR. Treatment for substance use disorder with co-occurring mental illness. Focus. 2019;17(2):88-97. [Link] [DOI:10.1176/appi.focus.20180042]
5. Volkow ND, Blanco C. Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023;22(2):203-29. [Link] [DOI:10.1002/wps.21073]
6. Guadalupe C, DeShong HL. Personality and coping: A systematic review of recent literature. Personal Individ Differ. 2025;239:113119. [Link] [DOI:10.1016/j.paid.2025.113119]
7. Carlon HA, Peters G, Villarosa-Hurlocker MC. When stimulant use becomes problematic: Examining the role of coping styles. Subst Use Misuse. 2022;57(3):442-51. [Link] [DOI:10.1080/10826084.2021.2019774]
8. Van Der Heijden HS, Schirmbeck F, Berry L, Simons CJP, Bartels-Velthuis AA, Bruggeman R, et al. Impact of coping styles on substance use in persons with psychosis, siblings, and controls. Schizophr Res. 2022;241:102-9. [Link] [DOI:10.1016/j.schres.2022.01.030]
9. Salem BA, Gonzales-Castaneda R, Ang A, Rawson RA, Dickerson D, Chudzynski J, et al. Craving among individuals with stimulant use disorder in residential social model-based treatment-Can exercise help?. Drug Alcohol Depend. 2022;231:109247. [Link] [DOI:10.1016/j.drugalcdep.2021.109247]
10. Cless MM, Courchesne-Krak NS, Bhatt KV, Mittal ML, Marienfeld CB. Craving among patients seeking treatment for substance use disorder. Discov Ment Health. 2023;3(1):23. [Link] [DOI:10.1007/s44192-023-00049-y]
11. Baillet E, Auriacombe M, Romao C, Garnier H, Gauld C, Vacher C, et al. Craving changes in first 14 days of addiction treatment: An outcome predictor of 5 years substance use status?. Transl Psychiatry. 2024;14(1):497. [Link] [DOI:10.1038/s41398-024-03193-3]
12. Musa ZA, Kim Lam S, Binti Mamat Mukhtar F, Kwong Yan S, Tajudeen Olalekan O, Kim Geok S. Effectiveness of mindfulness-based cognitive therapy on the management of depressive disorder: Systematic review. Int J Afr Nurs Sci. 2020;12:100200. [Link] [DOI:10.1016/j.ijans.2020.100200]
13. Biniyaz H, Shahabizadeh F. Effect of mindfulness-based cognitive therapy and intellectual-motor exercises in craving beliefs among industrial substance abusers. J Res Health. 2019;9(2):169-80. [Link] [DOI:10.29252/jrh.9.2.169]
14. Demina A, Petit B, Meille V, Trojak B. Mindfulness interventions for craving reduction in substance use disorders and behavioral addictions: Systematic review and meta-analysis of randomized controlled trials. BMC Neurosci. 2023;24(1):55. [Link] [DOI:10.1186/s12868-023-00821-4]
15. Melero Ventola AR, Yela JR, Crego A, Cortés-Rodríguez M. Effectiveness of a mindfulness-based cognitive therapy group intervention in reducing gambling-related craving. J Evid Based Psychother. 2020;20(1):107-34. [Link] [DOI:10.24193/jebp.2020.1.7]
16. Pilkington PD, Younan R, Karantzas GC. Identifying the research priorities for schema therapy: A Delphi consensus study. Clin Psychol Psychother. 2023;30(2):344-56. [Link] [DOI:10.1002/cpp.2800]
17. Uvelli A, Floridi M, Agrusti G, Franquillo AC, Fiumalbi L, Micheloni T, et al. When adverse experiences influence the interpretation of ourselves, others and the world: A systematic review and meta-analysis of maladaptive schemas in victims of violence. Clin Psychol Psychother. 2025;32(4):e70114. [Link] [DOI:10.1002/cpp.70114]
18. Talbot D, Harvey L, Cohn V, Truscott M. Combatting comorbidity: The promise of schema therapy in substance use disorder treatment. Discov Psychol. 2024;4(1):64. [Link] [DOI:10.1007/s44202-024-00179-6]
19. Lacy E. STAT: Schema therapy for addiction treatment, a proposal for the integrative treatment of addictive disorders. Front Psychol. 2024;15:1366617. [Link] [DOI:10.3389/fpsyg.2024.1366617]
20. Pourpashang M, Mousavi S. The effects of group schema therapy on psychological wellbeing and resilience in the clients under substance dependence treatment. J Client Cent Nurs Care. 2021;7(2):159-66. [Link] [DOI:10.32598/JCCNC.7.2.366.1]
21. Folkman S, Lazarus RS. Ways of coping questionnaire (WAYS). Database record. Washington, DC: APA PsycTests; 1988. [Link] [DOI:10.1037/t06501-000]
22. Taherkhani S. The factor structure of the ways of coping questionnaire among abused Iranian women. J Adult Prot. 2023;25(1):33-47. [Link] [DOI:10.1108/JAP-07-2022-0015]
23. Franken IH, Hendriksa VM, Van Den Brink W. Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav. 2002;27(5):675-85. [Link] [DOI:10.1016/S0306-4603(01)00201-5]
24. Amiri H, Makvandi B, Askari P, Naderi F, Ehteshamzadeh P. The effectiveness of matrix interventions in reducing the difficulty in cognitive emotion regulation and craving in methamphetamine-dependent patients. Shahroud J Med Sci. 2019;5(4). [Link]
25. Najafi Chaleshtori M, Asgari P, Heidari A, Dasht Bozorgi Z, Hafezi F. Effectiveness of mindfulness-based stress reduction intervention in distress tolerance and sensation-seeking in adolescents with a drug-addicted parent. J Res Health. 2022;12(5):355-62. [Link] [DOI:10.32598/JRH.12.5.1889.2]
26. Kebriti H, Zanjani Z, Omidi A, Sayyah M. Effect of mindfulness-based stress management therapy on emotion regulation, anxiety, depression, and food addiction in obese people: A randomized clinical trial. J Mazandaran Univ Med Sci. 2023;33(224):28-38. [Persian] [Link]
27. Naseri E. Efficacy of dual focus schema therapy in the treatment of people with substance use disorders comorbid with personality disorders. Clin Psychol Stud. 2020;11(41):43-65. [Persian] [Link]
28. SeyedAsiaban S, Manshaee GR, Askari P. Compare the effectiveness of schema therapy and mindfulness on psychosomatic symptoms in people with substance abuse stimulants. Res Addctn. 2017;10(40):181-99. [Persian] [Link]